News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN, page-37

Interesting broker data - see attached below between 1/5/2023 and 19/5/2023.

In particular, the largest buyer has been Jefferies...

They are U.S. based and big players in Biotech - Predominantly an insto broker, with private wealth/ bank.RAD recently participate in Jefferies Inaugural Radiopharma Innovation Summit, in April

In terms of radiopharmaceutical interest, Jefferies floated CU6 (184.8m MC currently and similar stage to RAD) and were LM of c.200m TLX raise also (3.622b MC currently).

Nice to see RAD appear to be on either U.S. based HNW or insto.